HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

caerulomycin A

structure in first source

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - caerulomycin A: 3

Experts

1.	Gurram, Rama Krishna: 2 articles (08/2017 - 10/2015)
2.	Kujur, Weshely: 2 articles (08/2017 - 10/2015)
3.	Maurya, Sudeep K: 2 articles (08/2017 - 10/2015)
4.	Agrewala, Javed Naim: 1 article (08/2017)
5.	Chodisetti, Sathi Babu: 1 article (08/2017)
6.	Khan, Nargis: 1 article (08/2017)
7.	Nadeem, Sajid: 1 article (08/2017)
8.	Agrewala, Javed N: 1 article (10/2015)
9.	Haleem, Nazia: 1 article (10/2015)

Related Diseases

1.	Asthma (Bronchial Asthma) 10/20/2015 - "In essence, this study signifies an important therapeutic role of Caerulomycin A in asthma. " 10/20/2015 - "Consequently, in the present study, we monitored the influence of Caerulomycin A in inhibiting the activity of Th2 cells and its impact in recuperating asthma symptoms. " 10/20/2015 - "Caerulomycin A inhibits Th2 cell activity: a possible role in the management of asthma."
2.	Neoplasms (Cancer) 10/01/2023 - "ω-transaminase CrmG is critical for the biosynthesis of Caerulomycin A, a natural product that possesses broad bioactivity, including immunosuppressive and anti-cancer. "
3.	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/01/2017 - "Caerulomycin A suppresses the differentiation of naïve T cells and alleviates the symptoms of experimental autoimmune encephalomyelitis."

Related Drugs and Biologics

1.	Transaminases (Aminotransferases)